Model simulations conducted in part to assess net monetary benefit found that comprehensive eye examinations every 3 years were more cost effective than less frequent examinations.

From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.

Bonnie An Henderson, MD, cofounder and program director of EnVision Summit, shares some of the unique qualities of the youth program.

Trending topics and milestone stories from our year in ophthalmology.

Researchers described the presence of multiple bilateral serous retinal detachments (SRDs) found in 3 women after they used hair dyes.

Let’s look back on some of the top stories on Modern Retina from 2024 as we gear up for an incredible 2025.

From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.

Catch up on what happened in optometry during the week of December 23-December 27.

EnVision Summit cofounder and program director Bonnie An Henderson, MD, chats about the new optometry track and what eye care providers can learn from each other.

While no infections or adverse events have been reported, fungal contamination can pose a serious risk of eye infections.

A look at the biggest news and advancements in ophthalmology in 2024.

The authors searched websites including PubMed, Scopus, MEDLINE, ScienceDirect, and ClinicalTrials.gov, and selected studies based on reports with an association between RVO and heart attack risk.

One of the new resources are Spanish closed captioning on educational videos to expand their reach to Latin American countries.

This year was brimming with advancements in eye care.

Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.

The global survey revealed similar challenges for individuals with unilateral and bilateral geographic atrophy.

Bonnie An Henderson, MD, shares a few of the emerging trends in eye care she and the faculty plan to tackle at the 2025 EnVision Summit.

If approved, Glaukos states that Epioxa would be the first FDA-approved, non-invasive corneal cross-linking therapy that does not require removal of the corneal epithelium.

According to Mile Brujic, OD, FAAO, low-level light therapy (LLLT) and intense pulsed light have demonstrated tremendous benefits for his patients.